Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings

MLA

Bosa Mirjanic-Azaric, et al. “Analysis of Redox Status and HDL Subclasses in Patients with Lymphoma and the Associations with FDG-PET/CT Findings.” Frontiers in Oncology, vol. 13, Oct. 2023. EBSCOhost, https://doi.org/10.3389/fonc.2023.1221414.

APA

Bosa Mirjanic-Azaric, Sinisa Stankovic, Lana Nezic, Zana Radic Savic, Dragana Malcic- Zanic, Ranko Skrbic, Jelena Kotur-Stevuljevic, & Natasa Bogavac-Stanojevic. (2023). Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1221414

Chicago

Bosa Mirjanic-Azaric, Sinisa Stankovic, Lana Nezic, Zana Radic Savic, Dragana Malcic- Zanic, Ranko Skrbic, Jelena Kotur-Stevuljevic, and Natasa Bogavac-Stanojevic. 2023. “Analysis of Redox Status and HDL Subclasses in Patients with Lymphoma and the Associations with FDG-PET/CT Findings.” Frontiers in Oncology 13 (October). doi:10.3389/fonc.2023.1221414.